Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)—SMART 2017–21

OBJECTIVES: To evaluate the in vitro activities of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Gram-negative bacilli collected in four central and northern European countries (Belgium, Norway, Sweden, Switzerland) during 2017–21. METHODS: Participating clinical labora...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A, Lob, Sibylle H, Hawser, Stephen P, Kothari, Nimmi, Siddiqui, Fakhar, Alekseeva, Irina, DeRyke, C Andrew, Young, Katherine, Motyl, Mary R, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416811/
https://www.ncbi.nlm.nih.gov/pubmed/37577157
http://dx.doi.org/10.1093/jacamr/dlad098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416811/
https://www.ncbi.nlm.nih.gov/pubmed/37577157
http://dx.doi.org/10.1093/jacamr/dlad098

Ejemplares similares